In a mouse model of lung cancer, it was found that knockout of the CCR2 gene or use of the CCR2 inhibitors inhibited the recruitment of TAMs and promoted their polarization into M1 phenotype, ultimately inhibiting the progression of lung cancer [159]. The gene discussed is CCR2; the disease is lung carcinoma.